Bristol Myers’ HCC Combo Drug Accepted for FDA Review – Bristol-Myers Squibb (NYSE:BMY)
Bristol Myers BMY introduced that the FDA has accepted its supplemental Biologics License Software (sBLA) for the immunotherapy drug, Opdivo ...
Tag: BristolMyers
Wall Street’s Most Accurate Analysts’ Views On 3 Health Care Stocks Delivering High-Dividend Yields – Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)
Throughout occasions of turbulence and uncertainty within the markets, many traders flip to dividend-yielding shares. These are sometimes corporations which ...
Bristol-Myers Squibb to acquire Karuna for $14 billion – WSJ By Investing.com
© Reuters. Bristol-Myers Squibb (BMY) to amass Karuna (KRTX) for $14 billion - WSJ Bristol Myers Squibb (NYSE:) has reportedly ...
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results | AlphaStreet
Biotechnology firm Bristol Myers Squibb (NYSE: BMY) Friday reported combined outcomes for the third quarter of 2023. The corporate additionally ...
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal By Reuters
© Reuters. FILE PHOTO: Check tubes are seen in entrance of a displayed Bristol Myers Squibb brand on this illustration ...